Clinical trials
Phase 4 trials in Mexico with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Guadalajara | 6 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 4 |
| Hospital General de Mexico | 3 |
| Instituto Mexicano del Seguro Social | 3 |
| National Institute of Respiratory Diseases, Mexico | 3 |
| Centro Universitario de Ciencias de la Salud, Mexico | 2 |
| Hospital Civil de Guadalajara | 2 |
| Hospital Universitario Dr. Jose E. Gonzalez | 2 |
| Universidad Autonoma de San Luis Potosí | 2 |
| Universidad Nacional Autonoma de Mexico | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Prediabetic State | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Asthma | 2 |
| Glucose Intolerance | 2 |
| HIV Infections | 2 |
| Heart Failure | 2 |
| Hyperglycemia | 2 |
| Hypertension | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.